Real-World study reveals how kidney patients use common drug
NCT ID NCT06203704
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study looked at how doctors in Central Eastern Europe prescribe dapagliflozin for chronic kidney disease (CKD) in routine care. Researchers collected data from medical records of over 1,000 adults to understand who gets the drug and what happens to their health over a year. The goal was to learn from real-world practice, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE(CKD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Plovdiv, Bulgaria
-
Research Site
Sofia, Bulgaria
-
Research Site
Varna, Bulgaria
-
Research Site
Zagreb, Croatia
-
Research Site
Békéscsaba, Hungary
-
Research Site
Budapest, Hungary
-
Research Site
Debrecen, Hungary
-
Research Site
Gödöllő, Hungary
-
Research Site
Karcag, Hungary
-
Research Site
Kecskemét, Hungary
-
Research Site
Miskolc, Hungary
-
Research Site
Nagykanizsa, Hungary
-
Research Site
Nyíregyháza, Hungary
-
Research Site
Pécs, Hungary
-
Research Site
Siófok, Hungary
-
Research Site
Szeged, Hungary
-
Research Site
Szombathely, Hungary
-
Research Site
Veszprém, Hungary
-
Research Site
Bialystok, Poland
-
Research Site
Bolesławiec, Poland
-
Research Site
Bydgoszcz, Poland
-
Research Site
Choszczno, Poland
-
Research Site
Czarnków, Poland
-
Research Site
Katowice, Poland
-
Research Site
Krakow, Poland
-
Research Site
Lodz, Poland
-
Research Site
Olsztyn, Poland
-
Research Site
Opole, Poland
-
Research Site
Sieradz, Poland
-
Research Site
Szczecin, Poland
-
Research Site
Środa Wielkopolska, Poland
-
Research Site
Węgrów, Poland
-
Research Site
Wroclaw, Poland
-
Research Site
Zielona Góra, Poland
-
Research Site
Żywiec, Poland
-
Research Site
Bistriţa, Romania
-
Research Site
Bucharest, Romania
-
Research Site
Cluj-Napoca, Romania
-
Research Site
Galati, Romania
-
Research Site
Iași, Romania
-
Research Site
Oradea, Romania
-
Research Site
Reşiţa, Romania
-
Research Site
Satu Mare, Romania
-
Research Site
Târgu Mureş, Romania
-
Research Site
Timișoara, Romania
-
Research Site
Belgrade, Serbia
-
Research Site
Brežice, Slovenia
-
Research Site
Cerknica, Slovenia
-
Research Site
Menges, Slovenia
-
Research Site
Portorož, Slovenia
-
Research Site
Ptuj, Slovenia
-
Research Site
Radlje ob Dravi, Slovenia
-
Research Site
Ruše, Slovenia
-
Research Site
Sevnica, Slovenia
-
Research Site
Škofja Loka, Slovenia
-
Research Site
Zagorje, Slovenia
Conditions
Explore the condition pages connected to this study.